Literature DB >> 1865184

Production of type 5 capsular polysaccharide by Staphylococcus aureus grown in a semi-synthetic medium.

B Dassy1, W T Stringfellow, M Lieb, J M Fournier.   

Abstract

The concentration of the type 5 capsular polysaccharide (CP) antigen of Staphylococcus aureus can be measured directly in cultures or cell suspensions by a two-step inhibition enzyme-linked immunosorbent assay (ELISA), using monoclonal antibodies. CP was synthesized during growth on a variety of carbon substrates and its production was not affected by the nature of the carbon source. High levels of yeast extract inhibited CP formation. CP was synthesized in batch culture at the same rate during exponential growth as in the post-exponential phase. Post-exponential CP production contributed at least half the final amount of CP measured. This phenomenon was observed in different culture media, although the specific yield of polysaccharide varied from one medium to another. Post-exponential CP production was observed in the pH range 6-7, but not at pH 8. Post-exponential production was strictly dependent on oxygen availability and did not occur under anaerobic conditions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1865184     DOI: 10.1099/00221287-137-5-1155

Source DB:  PubMed          Journal:  J Gen Microbiol        ISSN: 0022-1287


  15 in total

1.  Promoter analysis of the cap8 operon, involved in type 8 capsular polysaccharide production in Staphylococcus aureus.

Authors:  S Ouyang; S Sau; C Y Lee
Journal:  J Bacteriol       Date:  1999-04       Impact factor: 3.490

2.  Respiratory activity is essential for post-exponential-phase production of type 5 capsular polysaccharide by Staphylococcus aureus.

Authors:  B Dassy; J M Fournier
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Effects of culture conditions on production of type 5 capsular polysaccharide by human and bovine Staphylococcus aureus strains.

Authors:  B Poutrel; F B Gilbert; M Lebrun
Journal:  Clin Diagn Lab Immunol       Date:  1995-03

4.  Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.

Authors:  Caroline M Kusuma; John F Kokai-Kun
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Development and characterization of a Staphylococcus aureus nasal colonization model in mice.

Authors:  K B Kiser; J M Cantey-Kiser; J C Lee
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Staphylococcus aureus capsular polysaccharide types 5 and 8 reduce killing by bovine neutrophils in vitro.

Authors:  Annette H Kampen; Tore Tollersrud; Arve Lund
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Adherence of Staphylococcus aureus to endothelial cells: influence of capsular polysaccharide, global regulator agr, and bacterial growth phase.

Authors:  P Pöhlmann-Dietze; M Ulrich; K B Kiser; G Döring; J C Lee; J M Fournier; K Botzenhart; C Wolz
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 8.  Staphylococcus aureus capsular polysaccharides.

Authors:  Katherine O'Riordan; Jean C Lee
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

9.  Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus.

Authors:  J C Lee; S Takeda; P J Livolsi; L C Paoletti
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Staphylococcus aureus serotype 5 capsular polysaccharide is antiphagocytic and enhances bacterial virulence in a murine bacteremia model.

Authors:  M Thakker; J S Park; V Carey; J C Lee
Journal:  Infect Immun       Date:  1998-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.